Gastroenterology

Gastroenterology

Volume 107, Issue 5, November 1994, Pages 1550-1555
Gastroenterology

Hepatitis C virus and autoimmunity: Fortuitous association or reality?

https://doi.org/10.1016/0016-5085(94)90564-9Get rights and content

References (54)

  • LunelF et al.

    Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage

    Gastroenterology

    (1994)
  • Ruiz MorenoM et al.

    Autoimmune hepatitis type 2 manifested during Interferon therapy in children

    J Hepatol

    (1991)
  • SaraccoG et al.

    Autoantibodies and response to interferon in patients with chronic viral hepatitis

    J Hepatol

    (1990)
  • KoskinasJ et al.

    Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C

    Gastroenterology

    (1994)
  • CzajaAJ et al.

    Frequency and significance of antibodies to liver/kidney microsome type I in adults with chronic active hepatitis

    Gastroenterology

    (1992)
  • CzajaA et al.

    Evidence against hepatitis viruses as important causes of severe auto-immune hepatitis in the United States

    J Hepatol

    (1993)
  • SilvaE et al.

    Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis: a polymerase chain reaction and serological study

    J Hepatol

    (1993)
  • TodrosL et al.

    Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders

    J Hepatol

    (1991)
  • LöhrHF et al.

    In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C

    Gastroenterology

    (1994)
  • VolpesR et al.

    Can hepatocytes serve a ‘actived’ immunomodulating cells in the immune response?

    J Hepatol

    (1992)
  • MannsMP et al.

    Immunogenetics of chronic liver diseases

    Gastroenterology

    (1994)
  • MichitakaK et al.

    Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2

    Gastroenterology

    (1994)
  • ChooQL et al.

    Isolation of a cDNA clone derived from a blood-borne Non-A, Non-B viral hepatitis genome

    Science

    (1989)
  • HoughtonM et al.

    Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease

    Hepatology

    (1991)
  • FerriC et al.

    Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia

    Arthritis Rheum

    (1991)
  • LunelF et al.

    Liver/kidney microsome antibody type 1 and hepatitis C virus infection

    Hepatology

    (1992)
  • AlmazioP et al.

    Hepatitis C virus and Sjögren's Syndrome

    Lancet

    (1992)
  • Cited by (107)

    • Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients

      2018, Digestive and Liver Disease
      Citation Excerpt :

      CGs are heterogeneous immune-complexes, and do not always correlate with the severity of symptoms, [25]. HCV patients express a great variety of autoantibodies usually at a low titer [26], and they may be associated with underlying autoimmune disorders or liver inflammation in HCV infection. A possible reason for antibody production is over activation and proliferation of B lymphocytes, via interaction with the HCV surface protein [27].

    • Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders)

      2017, Clinics in Liver Disease
      Citation Excerpt :

      In a case-control study, patients with untreated HCV infection without hepatocellular carcinoma or cirrhosis (n = 630) were more likely to present with hypothyroidism and positive antithyroglobulin, and antithyroid peroxidase antibodies than healthy controls from both iodine-sufficient (n = 268) and -deficient areas (n = 389) and HBV-infected patients.55 In the past, several indirect mechanisms were discussed as potential links between these 2 conditions, especially the interference with self-recognition in the interaction between immune system and thyrocytes,56,57 including molecular mimicry or cross-reactivity of HCV with thyroid antigens,57,58 formation of heat shock proteins, and changes in major histocompatibility complex II antigens on thyrocytes.59 Interestingly, new evidence suggests that HCV can directly infect human thyroid cell lines, potentially contributing to the persistence of viral infection and to the development of thyroid autoimmunity through additional inflammatory mechanisms.60

    • Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders

      2016, Digestive and Liver Disease
      Citation Excerpt :

      HCV-patients show a wide range of autoantibodies usually at very low titres. Among them, ANA-positivity was found in 10–33% of HCV-patients [27]. Although an interpretation of the mechanism responsible for ANA onset and their clinical meaning are not clear, the molecular mimicry could, at least in part, explain this phenomenon.

    • Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: Report of two cases and review of the literature

      2015, Annals of Hepatology
      Citation Excerpt :

      It has also been observed the development and/or exacerbation5,13 of AIH in association with IFN alfa treatment for hepatitis C, a viral infection that per se has been related with autoimmunity.14 –16 Multiple sclerosis is a demyelinating disease of autoimmune nature resulting from dysregulation of TH1 and TH2 lymphocytes, cytokines and regulatory T cells.

    • Cryoglobulinemia and progression of fibrosis in chronic HCV infection: Cause or effect?

      2004, Journal of Infection
      Citation Excerpt :

      Prevalence of rheumatoid factor autoantibodies ranges from 24 to 76% in chronically HCV infected patients, and their frequency seems to increase with the severity of liver disease.15 The occurrence of RF activity with titers higher than 100 IU/ml closely correlates with HCV RNA in the serum and is a good predictor of the probability of isolating a cryoglobulin.16 A positivity rate for RF of 41.3% was found in the studied population and cryoglobulinemic patients showed higher RF positivity than those without cryoglobulinemia (p=0.02).

    View all citing articles on Scopus
    View full text